| Line item | 2025-12-31 FY | 2024-12-31 FY | 2024-06-30 FY | 2024-03-31 FY | 2023-12-31 FY | 2022-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $5.29B | $4.09B | $935.71M | $919.84M | $3.11B | $2.42B |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $415.07M | $343.81M | $136.67M | $46.91M | $213.66M | $149.01M |
| Operating Income | $309.60M | $123.07M | -$37.18M | $65.31M | $207.77M | $229.36M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $92.99M | $46.21M | -$19.12M | $22.88M | $44.44M | $56.55M |
| Net Income | $191.54M | $55.76M | -$31.88M | $34.82M | $112.87M | $150.50M |
| EPS (basic) | 1.2300 | 0.3800 | -0.2100 | 0.2700 | 0.8800 | 1.1700 |
| EPS (diluted) | 1.2200 | 0.3800 | -0.2100 | 0.2700 | 0.8800 | 1.1700 |
| Shares (diluted) | $156.70M | $148.57M | $149.46M | $128.72M | $128.72M | $128.72M |